Socioeconomic and Geographic Access to Novel Therapeutics: An Analysis of Growth in Transcatheter Aortic Valve Replacement Programs
Ashwin Nathan, M.D.1, Lin Yang2, Nancy Yang2, Sameed Khatana, MD, MPH3, Elias Dayoub, MD, MPP3, Lauren Eberly, MD, MPH1, Sreekanth Vemulapalli, MD4, Suzanne J. Baron, M.D., FSCAI5, David J. Cohen, M.D., FSCAI6, Nimesh Desai, MD PhD1, Joseph E. Bavaria7, Howard C. Herrmann, M.D., MSCAI7, Peter Groeneveld, MD, MS2, Jay S. Giri, MD, FSCAI1 and Alexander Craig Fanaroff, MD, MHS8, (1)Hospital of the University of Pennsylvania, Philadelphia, PA, (2)University of Pennsylvania, Philadelphia, PA, (3)Hospital of the University of Pennsylvania, Durham, NC, (4)Duke University Medical Center, Durham, NC, (5)Massachusets General Hospital , Winchester, MA, (6)St. Francis Hospital, New York, NY, (7)University of Pennsylvania Health System, Philadelphia, PA, (8)Hospital of the University of Pennsylvania, Gladwyne, PA